Trial Profile
Clinical Trials Insight: 700030550
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 13 Feb 2008
Price :
$35
*
At a glance
- Drugs Lersivirine (Primary) ; Antiretrovirals
- Indications HIV infections
- Focus Adverse reactions
- Sponsors Pfizer
- 13 Feb 2008 New trial record.